IL-23
-
Johnson vs. Johnson!
For more reports, please follow DrugTimes
-
First! FDA approves new indication for Johnson & Johnson’s IL-23 antibody
Congratulations to Johnson & Johnson!
For more reports, please follow DrugTimes
Congratulations to Johnson & Johnson!